Johnson Pharmacare Ltd (JOHNPHARMA) — shareholding pattern, promoter holding, financials and share price
About Johnson Pharmacare Ltd (JOHNPHARMA)
Johnson Pharmacare Ltd operates in the Diversified Commercial Services industry, within the Services sector. It trades on the NSE as JOHNPHARMA and on the BSE under scrip code 532154. Its ISIN is INE560F01022.
Incorporated in 1994, Johnson Pharmacare Ltd. (formerly Robinson Worldwide Trade Ltd) is involved in trading business and provides business services.
Johnson Pharmacare Limited is a pharmaceutical company engaged in purchasing and selling goods and services within India, with a focus on pharmaceuticals.
Founded in 1994, originally as Robinson Worldwide Trade Limited, the company underwent several name changes, reflecting shifts in its strategic direction.
Listed peers in Diversified Commercial Services: G-Tec Janix Education Ltd, Shreevatsaa Finance & Leasing Ltd, Monotype India Ltd, Innovative Ideals and Services India Ltd, Amalgamated Electricity Company Ltd, ERP Soft Systems Ltd.
Valuation & Returns
10 Jul 2026At ₹0.48 a share on 10 Jul 2026, Johnson Pharmacare Ltd (JOHNPHARMA) was valued at a price-to-book of 0.47x on a book value of ₹1.02 per share as of Mar 2025. Solomo computes return on equity of -99.2% and return on capital employed of -97.68% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- Industry P/E
- 21.24x
- P/B
- 0.47x
- EPS (TTM)
- ₹-1.01
- Book value / share
- ₹1.02
- ROE
- -99.2%
- ROCE
- -97.68%
- ROA
- -96.19%
- Debt / equity
- 0.01x
- Dividend yield
- 0%
- 52-week range
- ₹0.47 – ₹0.93
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Johnson Pharmacare Ltd (JOHNPHARMA) reported net profit of ₹-56 crore and earnings per share of ₹-1.01. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, net profit ₹-56 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 3 | 3 | 0 | 0 | 0 |
| Net profit (₹ cr) | 0 | -1 | 0 | -1 | -56 |
| EPS (₹) | 0 | -0.02 | 0 | -0.01 | -1.01 |
| Measure | 1Y |
|---|---|
| Profit growth | -190.00% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 0% of Johnson Pharmacare Ltd (JOHNPHARMA) (unchanged from the previous quarter). Market capitalisation was ₹26 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: Firm 1.47%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 0% | - | - | - | 100% |
| Mar 2026 | 0% | - | - | - | 100% |
| Dec 2025 | 0% | - | - | - | 100% |
| Sep 2025 | 0% | - | - | - | 100% |
| Jun 2025 | 0% | - | - | - | 100% |
| Mar 2025 | 0% | - | - | - | 100% |
| Dec 2024 | 0% | - | - | - | 100% |
| Sep 2024 | 0% | - | - | - | 100% |